Literature DB >> 14985544

NICE guidance for COPD.

D Halpin.   

Abstract

Entities:  

Mesh：

Year:  2004        PMID： 14985544      PMCID： PMC1746957          DOI： 10.1136/thx.2004.021113

Source DB:  PubMed          Journal:  Thorax        ISSN： 0040-6376            Impact factor:   9.139


× No keyword cloud information.
  10 in total

1.  Do symptoms predict COPD in smokers?

Authors:  Jill A Ohar; Alireza Sadeghnejad; Deborah A Meyers; James F Donohue; Eugene R Bleecker
Journal:  Chest       Date:  2010-04-02       Impact factor: 9.410

2.  Withdrawal of fluticasone propionate from combined salmeterol/fluticasone treatment in patients with COPD causes immediate and sustained disease deterioration: a randomised controlled trial.

Authors:  E F M Wouters; D S Postma; B Fokkens; W C J Hop; J Prins; A F Kuipers; H R Pasma; C A J Hensing; E C Creutzberg
Journal:  Thorax       Date:  2005-06       Impact factor: 9.139

3.  Evaluation of the effect of intra-operative intravenous fluid on post-operative pain and pulmonary function: a randomized trial comparing 10 and 30 ml kg(-1) of crystalloid.

Authors:  B D Straub; A Aslani; K Enohumah; R Rahore; I Conrick-Martin; D Kumar; M Campbell; P Dicker; E Mocanu; J P Loughrey; N E Hayes; C L McCaul
Journal:  Ir J Med Sci       Date:  2013-12-10       Impact factor: 1.568

4.  Long-acting muscarinic antagonist and long-acting β2-agonist therapy to optimize chronic obstructive pulmonary disease prior to lung cancer surgery.

Authors:  Takashi Makino; Hajime Otsuka; Yoshinobu Hata; Satoshi Koezuka; Yoko Azuma; Kazutoshi Isobe; Keishi Sugino; Satoru Ebihara; Sakae Homma; Akira Iyoda
Journal:  Mol Clin Oncol       Date:  2018-03-26

5.  A novel function of MUC18: amplification of lung inflammation during bacterial infection.

Authors:  Qun Wu; Stephanie R Case; Maisha N Minor; Di Jiang; Richard J Martin; Russell P Bowler; Jieru Wang; John Hartney; Anis Karimpour-Fard; Hong Wei Chu
Journal:  Am J Pathol       Date:  2012-12-17       Impact factor: 4.307

6.  Blood eosinophils to direct corticosteroid treatment of exacerbations of chronic obstructive pulmonary disease: a randomized placebo-controlled trial.

Authors:  Mona Bafadhel; Susan McKenna; Sarah Terry; Vijay Mistry; Mitesh Pancholi; Per Venge; David A Lomas; Michael R Barer; Sebastian L Johnston; Ian D Pavord; Christopher E Brightling
Journal:  Am J Respir Crit Care Med       Date:  2012-03-23       Impact factor: 21.405

7.  Characterisation of COPD heterogeneity in the ECLIPSE cohort.

Authors:  Alvar Agusti; Peter M A Calverley; Bartolome Celli; Harvey O Coxson; Lisa D Edwards; David A Lomas; William MacNee; Bruce E Miller; Steve Rennard; Edwin K Silverman; Ruth Tal-Singer; Emiel Wouters; Julie C Yates; Jørgen Vestbo
Journal:  Respir Res       Date:  2010-09-10

Review 8.  Optimizing management of chronic obstructive pulmonary disease in the upcoming decade.

Authors:  Richard Russell; Antonio Anzueto; Idelle Weisman
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2011-01-10

9.  Characteristics of undiagnosed COPD in a senior community center.

Authors:  Simeão Rodrigo Santos; Elisângela Silva Lizzi; Elcio Oliveira Vianna
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2014-10-15

10.  Using the Inflammacheck Device to Measure the Level of Exhaled Breath Condensate Hydrogen Peroxide in Patients With Asthma and Chronic Obstructive Pulmonary Disease (The EXHALE Pilot Study): Protocol for a Cross-Sectional Feasibility Study.

Authors:  Daniel M Neville; Carole Fogg; Thomas P Brown; Thomas L Jones; Eleanor Lanning; Paul Bassett; Anoop J Chauhan
Journal:  JMIR Res Protoc       Date:  2018-01-30
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.